Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide and GLP-1 receptor agonist and it is used as a medical weight loss treatment, leveraging its dual-action mechanism to regulate appetite and glucose metabolism. By enhancing feelings of fullness and improving insulin sensitivity, Tirzepatide supports effective weight management. This medical weight loss can demonstrate an average of 20% or more of the initial body weight.

Benefits: Improved metabolic health, cardiovascular health, glycemic control, appetite control,
and significant weight loss.
• 1st month supply 2.5mg: $300
• 2nd month supply 5mg: $400
• 3rd month supply 7.5mg: $500
• 4th month supply 10mg: $600
• 5th month supply 12.5mg: $700
• 6th month supply 15mg: $800